News1

The Ministry of Health and Welfare investigates medical institutions suspected of violating drug distribution principles by selling obesity treatment injections.

LG Innotek is partnering with Nvidia to develop advanced sensing solutions for physical AI and robotics, combining its camera and sensor technologies with Nvidia’s high-speed AI data-processing capabilities.

South Korean lab automation specialist Curiosis showcased its AI-powered self-driving laboratory technology at the 2026 World Bio Summit and held partnership talks with global pharmaceutical companies and overseas research institutions.

Hyundai Motor Group has publicly shared its accumulated experience in artificial intelligence transformation (AX), including implementation challenges and solutions, to help accelerate AI adoption across South Korean industries.

Hyundai Motor’s fifth-generation Tucson received 15,045 orders on its first day of sales, surpassing the previous record set by the model’s fourth generation in 2020.

Renault Korea has introduced new exterior and interior styling options for the 2027 Grand Koleos while lowering the price of a popular trim and expanding standard features on the Filante crossover.

South Korea joins top AI nations, recognized for model development and infrastructure investment, but faces challenges in industrial competitiveness.

Half of Americans fear AI may negatively impact politics and the economy, with job replacement being a major concern.

A predictive model has been developed to differentiate skin cancer and precancerous lesions using biopsy results and skin condition analysis.

South Korea and the World Health Organization have issued a joint declaration calling for responsible AI-driven healthcare innovation, stronger global cooperation and equitable access to its benefits regardless of a country’s wealth or income levels.

Celltrion is strengthening its European market presence through acquisitions, pharmacy-channel expansion and country-specific sales strategies, aiming to sustain growth in the fourth quarter following record quarterly results and rising sales of higher-margin products.

JNP Medi has introduced a beta version of Maven Safety AI Import, a new feature that uses AI to extract data from adverse event reports and automatically populate fields according to the ICH E2B(R3) electronic reporting standard to streamline pharmacovigilance workflows.

Samsung Bioepis announced that its investigational Nectin-4-targeting antibody-drug conjugate SBE303 has received U.S. FDA Fast Track designation for patients with locally advanced or metastatic urothelial cancer previously treated with a Nectin-4-targeted therapy.

Surgical AI robotics company Rosota has reported preclinical research demonstrating that AI trained on surgeons’ laparoscopic procedures can execute corresponding movements with a real robot, with testing in animals and postoperative survival monitoring.